Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0038454 (
stroke
)
147,016
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Osteoprotegerin
(
OPG
) is involved in the development of atherosclerosis and cardio-cerebrovascular disease. The goal of this meta-analysis was to evaluate the association of
OPG
single nucleotide polymorphisms (SNPs) with coronary artery disease (CAD) and ischemic
stroke
. A total of 15 eligible studies were extracted from electronic databases. Odds ratios (ORs) were presented, with 95% confidence intervals (CIs), to assess the associations. Meta-analysis was conducted using MetaGenyo, STATA, and Comprehensive Meta-Analysis. Meta-analysis of our data showed that the
OPG
SNP T950C was significantly associated with increased CAD risk among Asians via recessive (OR 1.55, 95% CI 1.18-2.04, P=0.002), CC vs TT (OR 1.57, 95% CI 1.16-2.11, P=0.003) and allelic (OR 1.21, 95% CI 1.05-1.38, P=0.007) models. No strong associations were observed for the
OPG
SNP G1181C, T245G and G209A with CAD risk. When evaluating the
OPG
SNP T245G and T950C associations with ischemic
stroke
, we found the
OPG
SNP T245G to be significantly associated with increased risk of ischemic
stroke
among Chinese via recessive (OR 1.53, 95% CI 1.02-2.29, P=0.039) and CC vs AA (OR 1.61, 95% CI 1.07-2.42, P=0.021) models. Our results suggested that the
OPG
SNP T950C was associated with increased risk of CAD among Asians, and the
OPG
SNP T245G was associated with enhanced ischemic
stroke
risk among Chinese.
...
PMID:Osteoprotegerin SNP associations with coronary artery disease and ischemic stroke risk: a meta-analysis. 3295 93
<< Previous
1
2
3